ArticleJournal, genetic engineering & biotechnology2025
Biodegradation of plastics and pesticides by soil bacteria in Bangladesh: Insights into antibiotic resistance and potential therapeutic targets.
Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bioremediation potential of lead and cadmium tolerant bacteria isolated from industrial (tannery) effluents.Journal, genetic engineering & biotechnology · 2026Article
- Microbial community characterization in semi-hydroponic systems of Starbor kale (Current research in microbial sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Soil bacteria exhibit varying degrees of tolerance to different concentrations of pesticides and plastics, and some possess the ability to degrade them, which is crucial for bioremediation. However, the multidrug-resistant properties of these bacteria pose challenges for their potential applications. Hence, this study aims to separate and characterize plastics and pesticide-degrading bacteria fromnon-contaminated and contaminated sites in Bangladesh and evaluate their antibiotic-resistant patterns to identify safety issues and discover promising therapeutic targets for combating multidrug-resistant infections. In the current study, a total of 90 soil samples were collected from different agricultural and dumped sites of Bangladesh, and bacterial isolates were screened for pesticides and plastics-degrading capabilities. Antibiotic sensitivity patterns of the potential isolates were evaluated using 16 different antibiotics. Biochemical, molecular, and genomic analyses were conducted to characterize the bacteria and identify antimicrobial resistance (AMR) genes. Our study screened out 122 plastic and 60 pesticide-tolerant bacterial isolates. Among them, 3 pesticide and 3 plastic-degrading isolates were found to be more promising and identified as Acinetobacter baumannii with pesticide-degrading capabilities from non-contaminated sites, and Klebsiella pneumoniae with plastic-degrading capabilities from contaminated sites. Antibiotic sensitivity test exhibited that most of the isolates were resistance to commonly used antimicrobials. The genomics and proteomics analysis uncovered the efflux pump-related genes responsible for the resistant mechanism and highlighted the involvement of genes that respond to antibiotics and transmembrane transport activities. Phylogenetic analysis confirmed the conservation of 2 common resistance genes adeF and gyrA, across diverse multidrug-resistant pathogens. Therefore, targeting conserved genes adeF and gyrA, to disrupt resistance mechanisms and combat persistent and clinically significant multidrug-resistant pathogens could be a promising strategy for developing combination therapies in medical science.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.